In this webinar, Dr. Lyles will explore:
A shift to universal nasal decolonization versus a targeted approach
The clinical and economic impact of universal nasal decolonization on patients and healthcare facilities
The evidence showing the importance of universal nasal decolonization in the reduction of infections caused by MDROs.
*Coates, T et al. Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. Journal of Antimicrobial Chemotherapy, July 2009; 64,9-15. Accessed at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692503/
Rosie D. Lyles, MD, MHA, MSc, is the Director of Clinical Affairs at Medline Industries, Inc. In this capacity, she serves as the subject matter expert on numerous healthcare matters, develops complex clinical strategies across multiple product lines and is the clinical lead for the company's healthcare businesses supporting the product life cycle